Parkside Elementary School youngsters hold “T-shirt” posters they created urging the Columbus North Bull Dog basketball team ...

which is an Alzheimer’s Society initiative changing the way people think, act and talk about dementia. There are already millions of Dementia Friends in England and Wales! Students who complete the ...

A groundbreaking peer-reviewed Thought Leaders Invited Review article in Brain Medicine (Genomic Press, New York) explores how CD2-associated protein (CD2AP) contributes to Alzheimer's disease (AD ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily ...

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

New Clue on What Is Leading to Neurodegenerative Diseases Like Alzheimer's and ALS Mar. 14, 2025 — Researchers have revealed a new scientific clue that could unlock the key cellular pathway ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

A risk factor is something that influences our chances developing a disease. There are a mix of risk factors for Alzheimer’s, some that we cannot control like our age and genetics, and some that we ...

Dementia is caused by different diseases that affect the brain, the most common being Alzheimer’s. Frontotemporal dementia, also known as FTD, is a rare type of dementia. It is thought to account for ...

As diplomatic tensions continue between Canada and the United States, a travel group says Islanders are rethinking their travel plans, opting for alternative vacation destinations that are either ...